title: Reply to "Antibiotics, intestinal dysbiosis and risk of celiac disease" by Hakim Rahmoune et al. [Digestive and Liver Disease].
authors.affiliation: Department of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia; Children's Clinic of Tartu University Hospital, Tartu, Estonia.
authors.forename: Kärt
authors.initials: K
authors.lastname: Simre
authors.affiliation: Children's Clinic of Tartu University Hospital, Tartu, Estonia; Department of Pediatrics, University of Tartu, Tartu, Estonia.
authors.forename: Oivi
authors.initials: O
authors.lastname: Uibo
authors.affiliation: Children's Clinic of Tartu University Hospital, Tartu, Estonia; Department of Pediatrics, University of Tartu, Tartu, Estonia.
authors.forename: Vallo
authors.initials: V
authors.lastname: Tillmann
authors.affiliation: Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland; Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland; Folkhälsan Research Center, Helsinki, Finland.
authors.forename: Mikael
authors.initials: M
authors.lastname: Knip
authors.affiliation: Department of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia. Electronic address: raivo.uibo@ut.ee.
authors.forename: Raivo
authors.initials: R
authors.lastname: Uibo
mesh_terms: D000900:Anti-Bacterial Agents; D002446:Celiac Disease; D064806:Dysbiosis; D006801:Humans; D007422:Intestines; D008107:Liver Diseases
chemical_list: D000900:Anti-Bacterial Agents